Chronic inflammatory demyelinating polyneuropathy: Clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy

Neurology

Volumn 48, Issue 2, 1997, Pages 321-328

  Gorson, Kenneth C ^a   Allam, Gregory ^a   Ropper, Allan H ^a  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE COURSE; ELECTROMYOGRAM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMAPHERESIS; POLYNEUROPATHY; PRIORITY JOURNAL; SYNDROME DELINEATION;

EID: 0031019278     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.2.321     Document Type: Article

References (50)

1. Simmons Z, Albers JW, Bromberg MB, Feldman EL. Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyneuropathy: comparison of patients without and with monoclonal gammopathy. Neurology 1993;43:2202-2209.
2. Barohn RJ, Kissel JT, Warmolts JR, Mendell JR. Chronic inflammatory demyelinating polyneuropathy: clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 1989;46:878-884.
3. McCombe PA, Pollard JD, McLeod JG. Chronic inflammatory polyradiculoneuropathy: a clinical and electrophysiological study of 92 cases. Brain 1987;110:1617-1630.
4. Dyck PJ, Lais AC, Ohta M, Bastron JA, Okazaki H, Groover RV. Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc 1975;50:621-637.
5. Bromberg MB. Comparison of electrodiagnostic criteria for primary demyelination in chronic polyneuropathy. Muscle Nerve 1991;14:968-976.
6. Albers JW, Kelly JJ. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve 1989;12:435-451.
7. Prineas JW, McLeod JG. Chronic relapsing polyneuritis. J Neurol Sci 1976;27:427-458.
8. Krendel DA, Parks HP, Anthony DC, St. Clair MB, Graham DG. Sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 1989;12:257-264.
9. Simmons Z, Albers JW, Bromberg MB, Feldman EL. Long-term followup of patients with chronic inflammatory demyelinating polyneuropathy, without and with monoclonal gammopathy. Brain 1995;118:359-368.
10. Choudhary PP, Hughes RAC. Long-term treatment of chronic inflammatory demyelinating polyradiculoneuropathy with plasma exchange or intravenous gammaglobulin. QJM 1995; 88:493-502.
11. Hughes RAC. Chronic inflammatory demyelinating polyneuropathy. In: Hughes RAC, ed. Guillain-Barré syndrome. London: Springer-Verlag, 1990:205-246.
12. Dyck PJ, Prineas J, Pollard J. Chronic inflammatory demyelinating polyneuropathy. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Podulos JF, eds. Peripheral neuropathy. Philadelphia, PA: WB Saunders, 1993:1498-1517.
13. Cornblath DR, Asbury AK, Albers JW, et al. Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for the diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991;41:617-618.
14. Keren DF, Warren JS, Lowe JB. Strategy to diagnose monoclonal gammopathies in serum: high-resolution electrophoresis, immunofixation, and k/l quantification. Clin Chem 1988; 34:2196-2201.
15. Gorson KC, Ropper AH. Polyneuropathy associated with polyclonal gammopathy [abstract]. Ann Neurol 1994;36:286.
16. Austin JH. Recurrent polyneuropathies and their corticosteroid treatment. Brain 1958;81:157-192.
17. Mathews WB, Howell DA, Hughes RC. Relapsing corticosteroid-dependent polyneuritis. J Neurol Neurosurg Psychiatry 1970;33:330-337.
18. Thomas PK, Lacelles RG, Hallpike JF, Hewer RL. Recurrent and chronic relapsing Guillain-Barré polyneuritis. Brain 1969;92:589-606.
19. Dalakas MC, Engel WK. Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment. Ann Neurol 1981; 9(suppl):134-145.
20. Bromberg MB, Feldman EL, Albers JW. Chronic inflammatory demyelinating polyneuropathy: comparison of patients with and without an associated monoclonal gammopathy. Neurology 1992;42:1157-1163.
21. Small GA, Lovelace RE. Chronic inflammatory demyelinating polyneuropathy. Semin Neurol 1993;13:305-312.
22. Ropper AH. Relapsing and chronic inflammatory polyneuropathy. In: Ropper AH, Wijdicks EFM, Truax BT, eds. Guillain-Barré syndrome. Philadelphia, PA: FA Davis, 1991:128-145.
23. Gosselin S, Kyle RA, Dyck PJ. Neuropathy associated with monoclonal gammopathies of uncertain significance. Ann Neurol 1991;30:54-61.
24. Ropper AH. Further regional variants of acute immune polyneuropathy. Arch Neurol 1994;51:671-675.
25. Ropper AH. Unusual clinical variants and signs in Guillain-Barré syndrome. Arch Neurol 1986;43:1150-1152.
26. Dawson DM, Samuels MA, Morris J. Sensory form of acute polyneuritis. Neurology 1988;38:1728-1730.
27. Visser LH, van der Meche FGA, van Doorn PA, et al. Guillain-Barré syndrome without sensory loss (acute motor neuropathy). Brain 1995;118:841-847.
28. Parry GJ. Motor neuropathy with multifocal motor conduction block. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Podulos JF, eds. Peripheral neuropathy. Philadelphia, PA: WB Saunders, 1993:1518-1524.
29. Parry GJ, Sumner AJ. Multifocal motor neuropathy. Neurol Clin 1992;10:671-684.
30. Kornberg AJ, Pestronk A. Chronic motor neuropathies: diagnosis, therapy, and pathogenesis. Ann Neurol 1995;37(suppl 1):S43-S50.
31. Krarup C, Stewart JD, Sumner AJ, Pestronk A, Lipton SA. A syndrome of asymmetric limb weakness with motor conduction block. Neurology 1990;40:118-127.
32. Pestronk A, Cornblath DR, Ilyas AA, et al. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 1988;24:73-78.
33. Donaghy M, Mills KR, Boniface SJ, et al. Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry 1994;57:778-783.
34. Oh SJ, Joy JL, Kuruoglu R. Chronic sensory demyelinating neuropathy: chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy. J Neurol Neurosurg Psychiatry 1992;55:677-680.
35. Lewis RA, Sumner AJ, Brown MJ, Asbury AK. Multifocal demyelinating neuropathy with persistent conduction block. Neurology 1982;32:958-964.
36. Asbury AK, Thomas PK. The clinical approach to neuropathy. In: Asbury AK, Thomas PK, eds. Peripheral nerve disorders 2. Oxford: Butterworth-Heinemann, 1995:1-29.
37. Muriello MA, Gorson KC, Hayes MT, Ropper AH. Acute Guillain-Barré syndrome as the initial presentation of relapsing chronic inflammatory polyneuropathy [abstract]. Ann Neurol 1995;38:302.
38. Notermans NC, Wokke JHJ, Lokhorst HM, Franssen H, van der Graaf Y, Jennekens FGI. Polyneuropathy associated with monoclonal gammopathy of undetermined significance: a prospective study of the prognostic value of clinical and laboratory abnormalities. Brain 1994;117:1385-1393.
39. Suarez GA, Kelly JJ. Polyneuropathy associated with monoclonal gammopathy of undetermined significance: further evidence that IgM-MGUS neuropathies are different than IgG-MGUS. Neurology 1993;43:1304-1308.
40. Kyle RA, Dyck PJ. Neuropathies associated with monoclonal gammopathies. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Podulos JF, eds. Peripheral neuropathy. Philadelphia, PA: WB Saunders, 1993:1275-1287.
41. Dellagi K, Chedru F, Clauvel JP, Brouet JJC. Neuropathic peripherique de la macroglobulinemie de Waldenstrom. Presse Med 1984;13:119-1201.
42. Sherman WH, Olarte MR, McKiernan G, Sweeney K, Latov N, Hays AP. Plasma exchange treatment of peripheral neuropathy associated with plasma cell dyscrasia. J Neurol Neurosurg Psychiatry 1984;47:813-819.
43. Ernerudh J, Brodtkorb E, Olsson T, et al. Peripheral neuropathy and monoclonal IgM with antibody activity against peripheral nerve myelin: effect of plasma exchange. J Neuroimmunol 1986;11:171-178.
44. Dyck PJ, Low PA, Windebank AJ, et al. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med 1991;325:1482-1486.
45. Dyck PJ, Daube J, O Brien P, et al. Plasma exchange in chronic inflammatory demyelinating polyneuropathy. N Engl J Med 1986;314:461-465.
46. Pollard JD, McLeod JG, Gatenby P, Kronenberg H. Prediction of response to plasma exchange in chronic relapsing polyneuropathy: a clinical-pathological correlation. J Neurol Sci 1983: 58:269-287.
47. Gross MLP, Thomas PK. The treatment of chronic relapsing and chronic progressive idiopathic inflammatory polyneuropathy by plasma exchange. J Neurol Sci 1981;52:69-78.
48. van der Meche FGA, van Doom PA. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies. Ann Neurol 1995;37(suppl 1):S14-S31.
49. Nemni R, Amadio S, Fazio R, Galardi G, Previtali S, Comi G. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating neuropathy not responsive to other treatments. J Neurol Neurosurg Psychiatry 1994;57(suppl):43-45.
50. Dyck PJ, Litchy WJ, Kratz KM, et al. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 1994; 36:838-845.